{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:37:51Z","timestamp":1774417071388,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,12]]},"DOI":"10.7759\/cureus.82140","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:14:20Z","timestamp":1744492460000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Primary Peritoneal Adenocarcinoma: Diagnostic and Therapeutic Challenges"],"prefix":"10.7759","author":[{"given":"Imran","family":"Bitar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Waggoner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Alzayadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Abushaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199905000-00023","article-title":"Primary peritoneal carcinoma: a review of the literature","volume":"54","author":"Chu CS","year":"1999","unstructured":"Chu CS, Menzin AW, Leonard DG, Rubin SC, Wheeler JE. Primary peritoneal carcinoma: a review of the literature. Obstet Gynecol Surv. 1999, 54:323-35. 10.1097\/00006254-199905000-00023","journal-title":"Obstet Gynecol Surv"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cort\u00e9s-Guiral D","year":"2021","unstructured":"Cort\u00e9s-Guiral D, H\u00fcbner M, Alyami M, et al.. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers. 2021, 7:91. 10.1038\/s41572-021-00326-6","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0771","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004","volume":"18","author":"Goodman MT","year":"2009","unstructured":"Goodman MT, Shvetsov YB. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. Cancer Epidemiol Biomarkers Prev. 2009, 18:132-9. 10.1158\/1055-9965.EPI-08-0771","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2014.879571","article-title":"Peritoneal cancer treatment","volume":"15","author":"Yonemura Y","year":"2014","unstructured":"Yonemura Y, Canbay E, Endou Y, et al.. Peritoneal cancer treatment. Expert Opin Pharmacother. 2014, 15:623-36. 10.1517\/14656566.2014.879571","journal-title":"Expert Opin Pharmacother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B0820051","article-title":"Advanced primary peritoneal carcinoma: clinicopathological and prognostic factor analyses","volume":"9","author":"Zhang C","year":"2008","unstructured":"Zhang C, Li XP, Cui H, Shen DH, Wei LH. Advanced primary peritoneal carcinoma: clinicopathological and prognostic factor analyses. J Zhejiang Univ Sci B. 2008, 9:435-40. 10.1631\/jzus.B0820051","journal-title":"J Zhejiang Univ Sci B"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.1996.tb01133.x","article-title":"Primary peritoneal carcinoma: a treatable subset of patients with adenocarcinoma of unknown primary","volume":"66","author":"Della-Fiorentina SA","year":"1996","unstructured":"Della-Fiorentina SA, Jaworski RC, Crandon AJ, Harnett PR. Primary peritoneal carcinoma: a treatable subset of patients with adenocarcinoma of unknown primary. Aust N Z J Surg. 1996, 66:124-5. 10.1111\/j.1445-2197.1996.tb01133.x","journal-title":"Aust N Z J Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00675-5","article-title":"Advances in the management of peritoneal malignancies","volume":"19","author":"Kepenekian V","year":"2022","unstructured":"Kepenekian V, Bhatt A, P\u00e9ron J, et al.. Advances in the management of peritoneal malignancies. Nat Rev Clin Oncol. 2022, 19:698-718. 10.1038\/s41571-022-00675-5","journal-title":"Nat Rev Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2012.654871","article-title":"Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics","volume":"30","author":"Br\u00fccher BL","year":"2012","unstructured":"Br\u00fccher BL, Piso P, Verwaal V, et al.. Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics. Cancer Invest. 2012, 30:209-24. 10.3109\/07357907.2012.654871","journal-title":"Cancer Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.06.007","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care","volume":"48","author":"Sugarbaker PH","year":"2016","unstructured":"Sugarbaker PH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care. Cancer Treat Rev. 2016, 48:42-9. 10.1016\/j.ctrv.2016.06.007","journal-title":"Cancer Treat Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-7-5","article-title":"Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"7","author":"Glockzin G","year":"2009","unstructured":"Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009, 7:5. 10.1186\/1477-7819-7-5","journal-title":"World J Surg Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16480","article-title":"Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy","volume":"8","author":"McMullen JR","year":"2017","unstructured":"McMullen JR, Selleck M, Wall NR, Senthil M. Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy. Oncotarget. 2017, 8:43481-90. 10.18632\/oncotarget.16480","journal-title":"Oncotarget"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08832-9","article-title":"Peritoneal cell-free tumor DNA as biomarker for peritoneal surface malignancies","volume":"27","author":"Leick KM","year":"2020","unstructured":"Leick KM, Kazarian AG, Rajput M, et al.. Peritoneal cell-free tumor DNA as biomarker for peritoneal surface malignancies. Ann Surg Oncol. 2020, 27:5065-71. 10.1245\/s10434-020-08832-9","journal-title":"Ann Surg Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/17588359241233225","article-title":"Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4","volume":"16","author":"Ghose A","year":"2024","unstructured":"Ghose A, McCann L, Makker S, et al.. Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4. Ther Adv Med Oncol. 2024, 16:17588359241233225. 10.1177\/17588359241233225","journal-title":"Ther Adv Med Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2017.1326820","article-title":"The role of biomarkers in the management of epithelial ovarian cancer","volume":"17","author":"Yang WL","year":"2017","unstructured":"Yang WL, Lu Z, Bast RC Jr. The role of biomarkers in the management of epithelial ovarian cancer. Expert Rev Mol Diagn. 2017, 17:577-91. 10.1080\/14737159.2017.1326820","journal-title":"Expert Rev Mol Diagn"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25356","article-title":"Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients","volume":"116","author":"Glehen O","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, et al.. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010, 116:5608-18. 10.1002\/cncr.25356","journal-title":"Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/353549-a-case-of-primary-peritoneal-adenocarcinoma-diagnostic-and-therapeutic-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:14:21Z","timestamp":1744492461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/353549-a-case-of-primary-peritoneal-adenocarcinoma-diagnostic-and-therapeutic-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.82140","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,12]]}}}